Paratek Pharmaceuticals - Company & Market Research Reports

Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of therapeutics based upon tetracycline chemistry. Its lead product candidates include Omadacycline and Sarecycline, both of which are undergoing clinical trials. It has collaborative research and license agreement with Allergan plc to research and develop tetracycline products. Paratek was incorporated in 2001 and is based in Boston, Massachusetts.


Antibiotics: the Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts - Product Thumbnail Image

Antibiotics: the Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts

  • Report
  • 299 Pages
From
Global Antibiotics Market 2017-2021 - Product Thumbnail Image

Global Antibiotics Market 2017-2021

  • Report
  • 118 Pages
From
Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026

  • Report
  • 49 Pages
From
Pneumonia Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pneumonia Drug Development Pipeline Review, 2017

  • Report
  • 123 Pages
From
2018 Community- Acquired Pneumonia (CAP) Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Community- Acquired Pneumonia (CAP) Drug Development- Pipeline Analysis Report

  • Report
  • 50 Pages
From
Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • 91 Pages
From
Urinary Tract Infections - Pipeline Insight, 2018 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Urinary Tract Infections - Pipeline Review, H2 2015 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Review, H2 2015

  • Report
  • 139 Pages
From
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018

  • Report
  • 112 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Insight, 2018 - Product Thumbnail Image

Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Skin Infections - Pipeline Review, H1 2014 - Product Thumbnail Image

Skin Infections - Pipeline Review, H1 2014

  • Report
  • 183 Pages
From
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026  - Product Thumbnail Image

Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026

  • Report
  • 266 Pages
From
Antibiotic Resistance Markets - Pharmaceutical Therapeutics - By Pathogen and Therapy Type Strategies & Trends 2018 to 2023 - Product Thumbnail Image

Antibiotic Resistance Markets - Pharmaceutical Therapeutics - By Pathogen and Therapy Type Strategies & Trends 2018 to 2023

  • Report
  • 279 Pages
From
Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria - Product Thumbnail Image

Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria

  • Report
  • 111 Pages
From
Hypoxemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hypoxemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 50 Pages
From
Pneumonia Therapeutics Market Analysis By Product (Drugs, Branded, Quinolones, Aminopenicillins, Macrolides, B-lactamase Inhibitors, Cephalosporins, Tetracyclines, Glycopeptides, Generics, Vaccines, Oxygen Therapy) And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Pneumonia Therapeutics Market Analysis By Product (Drugs, Branded, Quinolones, Aminopenicillins, Macrolides, B-lactamase Inhibitors, Cephalosporins, Tetracyclines, Glycopeptides, Generics, Vaccines, Oxygen Therapy) And Segment Forecasts, 2014 - 2025

  • Report
  • 102 Pages
From
Community Acquired Pneumonia - Pipeline Review, H1 2018 - Product Thumbnail Image

Community Acquired Pneumonia - Pipeline Review, H1 2018

  • Report
  • 114 Pages
From
Community Acquired Pneumonia - Pipeline Review, H2 2017 - Product Thumbnail Image

Community Acquired Pneumonia - Pipeline Review, H2 2017

  • Report
  • 106 Pages
From
Community Acquired Pneumonia - Pipeline Insight, 2018 - Product Thumbnail Image

Community Acquired Pneumonia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Loading Indicator
adroll